前列腺癌核医学成像的适应症。

Q4 Medicine

Ugeskrift for laeger Pub Date : 2024-08-12 DOI:10.61409/V01240036

Andreas Underbjerg Raade, Karen Middelbo Buch-Olsen, Lars Lund, Helle D Zacho, Michael Borre, Jorun Holm, Kasper Tholstrup Pedersen, Malene Brubbe Hildebrandt

{"title":"前列腺癌核医学成像的适应症。","authors":"Andreas Underbjerg Raade, Karen Middelbo Buch-Olsen, Lars Lund, Helle D Zacho, Michael Borre, Jorun Holm, Kasper Tholstrup Pedersen, Malene Brubbe Hildebrandt","doi":"10.61409/V01240036","DOIUrl":null,"url":null,"abstract":"Nuclear medicine imaging for prostate cancer has advanced significantly over the past decade. A survey is presented in this review. PSMA-PET/CT is a new highly accurate method that has been introduced, but bone scans and bone-PET continue to be widely applied. PSMA-PET/CT still lacks sufficient patient outcome data to be recommended for treatment allocation when used for primary staging. However, the literature and clinical guidelines support its use at the stage of biochemical recurrence. In Denmark, the use of nuclear medicine examinations for prostate cancer aligns with clinical guideline recommendations.","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Indications for nuclear medicine imaging in prostate cancer.\",\"authors\":\"Andreas Underbjerg Raade, Karen Middelbo Buch-Olsen, Lars Lund, Helle D Zacho, Michael Borre, Jorun Holm, Kasper Tholstrup Pedersen, Malene Brubbe Hildebrandt\",\"doi\":\"10.61409/V01240036\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nuclear medicine imaging for prostate cancer has advanced significantly over the past decade. A survey is presented in this review. PSMA-PET/CT is a new highly accurate method that has been introduced, but bone scans and bone-PET continue to be widely applied. PSMA-PET/CT still lacks sufficient patient outcome data to be recommended for treatment allocation when used for primary staging. However, the literature and clinical guidelines support its use at the stage of biochemical recurrence. In Denmark, the use of nuclear medicine examinations for prostate cancer aligns with clinical guideline recommendations.\",\"PeriodicalId\":23428,\"journal\":{\"name\":\"Ugeskrift for laeger\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ugeskrift for laeger\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.61409/V01240036\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ugeskrift for laeger","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.61409/V01240036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

在过去十年中，前列腺癌核医学成像技术取得了长足的进步。本综述对此进行了概述。PSMA-PET/CT是一种新推出的高精度方法，但骨扫描和骨PET仍在广泛应用。PSMA-PET/CT仍缺乏足够的患者疗效数据，因此在用于初级分期时，无法推荐用于治疗分配。不过，文献和临床指南都支持在生化复发阶段使用该方法。在丹麦，前列腺癌核医学检查的使用符合临床指南的建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Indications for nuclear medicine imaging in prostate cancer.

Nuclear medicine imaging for prostate cancer has advanced significantly over the past decade. A survey is presented in this review. PSMA-PET/CT is a new highly accurate method that has been introduced, but bone scans and bone-PET continue to be widely applied. PSMA-PET/CT still lacks sufficient patient outcome data to be recommended for treatment allocation when used for primary staging. However, the literature and clinical guidelines support its use at the stage of biochemical recurrence. In Denmark, the use of nuclear medicine examinations for prostate cancer aligns with clinical guideline recommendations.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Ugeskrift for laeger Medicine-Medicine (all)

CiteScore

0.20

自引率

0.00%

发文量

345

期刊介绍： The Ulster Medical Journal is an international general medical journal with contributions on all areas of medical and surgical specialties relevant to a general medical readership. It retains a focus on material relevant to the health of the Northern Ireland population. The Honorary Editor would welcome offers of papers for publication. Prospective authors are invited to read the notice to contributors.